CDMO Lonza strikes deal with Allarity Therapeutics to manufacture cancer drug candidate dovitinib

CDMO Lonza strikes deal with Allarity Therapeutics to manufacture cancer drug candidate dovitinib
kdunleavy
Thu, 09/23/2021 – 15:42